Streetbeat News

Price Targets

ARAV

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Aravive (NASDAQ:ARAV) and maintained a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2023 | 4:38 pm

ARE

Evercore ISI Group analyst Steve Sakwa maintains an 'Outperform' rating on Alexandria Real Estate (NYSE:ARE), but lowers the price target from $141 to $137.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2023 | 4:36 pm

UPS

A significant amount of unusual options activity has been observed for United Parcel Service (NYSE:UPS), with a bearish stance being taken by a majority of investors. The targeted price range for UPS over the last 3 months has been between $105.0 and $195.0. The company's stock is currently up 2.6% at $183.91, but RSI indicators suggest it may be overbought. Atlantic Equities has downgraded its action to Neutral with a price target of $162.

Portfolio Pulse from Benzinga Insights

July 03, 2023 | 4:19 pm

KRYS

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Krystal Biotech (NASDAQ:KRYS) and maintained a price target of $139.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2023 | 4:19 pm

PTGX

BTIG analyst Julian Harrison has reiterated a 'Buy' rating on Protagonist Therapeutics (NASDAQ:PTGX) and maintained a price target of $41.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2023 | 4:11 pm

XOM

A significant investor has taken a bullish stance on Exxon Mobil (NYSE:XOM), with 58% of recent trades being bullish and 41% bearish. The total amount for puts was $184,896 and for calls was $771,488. The targeted price range for Exxon Mobil over the last 3 months has been $90.0 to $125.0. The current price of XOM is up 0.98% at $108.3. Piper Sandler maintains an Overweight rating on Exxon Mobil with a price target of $127.

Portfolio Pulse from Benzinga Insights

July 03, 2023 | 4:03 pm

BMRN

Over the past 3 months, 13 analysts have published their opinion on Biomarin Pharmaceutical (NASDAQ:BMRN) stock. The company has an average price target of $109.54 with a high of $140.00 and a low of $69.00. The average price target has increased by 1.24% over the past month.

Portfolio Pulse from Benzinga Insights

July 03, 2023 | 3:00 pm

ENSC

HC Wainwright has initiated coverage on Ensysce Biosciences with a Buy rating and a price target of $9. This has led to a rise in Ensysce Biosciences' stock price.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2023 | 2:13 pm

ZIM

JP Morgan analyst Samuel Bland has maintained a Neutral rating on ZIM Integrated Shipping (NYSE:ZIM) and lowered the price target from $17.8 to $17.7.

Portfolio Pulse from richadhand@benzinga.com

July 03, 2023 | 2:07 pm

TSLA

Goldman Sachs analyst Mark Delaney maintains a Neutral rating on Tesla (NASDAQ:TSLA) and raises the price target from $248 to $275.

Portfolio Pulse from richadhand@benzinga.com

July 03, 2023 | 2:06 pm